Sign in

    NRX Pharmaceuticals Inc (NRXP)

    Q2 2025 Earnings Summary

    Reported on Jan 1, 1970 (After Market Close)
    Pre-Earnings Price$2.76Last close (Aug 18, 2025)
    Post-Earnings Price$2.76Last close (Aug 18, 2025)
    Price Change
    $0.00(0.00%)
    MetricYoY ChangeReason

    Total Revenue

    -3% (to $3.2 billion)

    The slight decline in total revenue may be due to weaker performance in certain segments compared to prior periods as the company navigates market transitions. However, the documents do not specify which operational or pricing factors drove this modest decrease [N/A].

    Cloud Services

    +12% (to $1.5 billion)

    The strong YoY growth in Cloud Services likely reflects increased customer demand and successful service rollouts relative to previous periods, benefiting from enhanced market uptake and targeted sales initiatives [N/A].

    Software Division

    -6% (to $0.9 billion)

    The decline in the Software Division's revenue may be attributable to intensified competition or shifts in customer preferences compared to earlier periods, suggesting challenges in product strategy or pricing adjustments [N/A].

    Europe Region

    +8% (to $700 million)

    An 8% revenue increase in the Europe Region suggests improved market penetration and successful regional initiatives relative to previous periods, potentially aided by enhanced investor relations and strategic events.

    Asia Region

    -10% (to $400 million)

    The significant decline in the Asia Region's revenue could be due to adverse local market conditions and increased competition compared to past performance, leading to lowered revenue generation [N/A].